重组抗小鼠CD11c单抗(N418) | Syd Labs PA007390.m1
体内实验级重组抗小鼠CD11c单抗,小鼠IgG1 kappa(克隆号:N418,货号:PA007390.m1)是用哺乳动物细胞生产的重组抗体,纯度>95%,适用于体外和体内研究,比如体内树突状细胞耗竭(清除)。Syd Labs PA007390.m1 抗小鼠CD11c抗体不变区为小鼠Mouse IgG1 Kappa (mIgG1或m1),可与重组小鼠IgG1同型对照抗体配套使用。样品制备条件和最佳样品稀释度应由研究人员通过实验确定。
产品参数
| 货号 | PA007390.m1 |
|---|---|
| 产品名称 | 重组抗小鼠CD11c单抗(N418) | Syd Labs PA007390.m1 |
| 英文名 | In vivo Grade Recombinant Anti-mouse CD11c Monoclonal Antibody, Mouse IgG1 Kappa (Clone: N418) |
| 供货商名称 | Syd Labs, Inc. |
| 品牌名 | Syd Labs |
| 别称 | αX整合素,CR4,p150,整合素αX |
| 概述 | Syd Labs提供重组小鼠IgG1同型对照抗体。样品制备条件和最佳样品稀释应由研究人员通过实验确定。 |
| 克隆号 | N418 |
| 同种型 | 小鼠 IgG1 kappa |
| 应用 | ELISA、流式细胞术、中和、功能测定,如生物分析PK和ADA测定,以及用于研究受小鼠CD11c蛋白影响的生物途径的测定。 |
| 免疫源 | 体内实验级重组抗小鼠CD11c单抗(克隆:N418)在哺乳动物细胞中产生 |
| 抗体形式 | 0.2 μM过滤溶液,1x PBS |
| 内毒素 | 根据 LAL 方法,≤1 EU每1mg 蛋白质 |
| 纯度 | >95%(在还原条件下通过SDS-PAGE测定) |
| 运输 | 体内实验级重组抗小鼠CD11c单克隆抗体,小鼠 IgG1 kappa(克隆号N418) 用冰袋运输。收到后,请立即将其存放在下面建议的温度下。 |
| 稳定性与存储 | 使用手动除霜冰箱并避免重复冻融循环。 自收到之日起 1 个月,保存在2 至 8°C。 自收到之日起12个月,保存在-20 至 -70°C。 |
| 注意事项 | PA007390.m1 Syd Labs:体内实验级重组抗小鼠CD11c单抗是用哺乳动物细胞生产的重组抗体,可与重组小鼠IgG1同型对照抗体配套使用。样品制备条件和最佳样品稀释应由研究人员通过实验确定。 |
| 产品咨询 | Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。 关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理) |
| 应用详情 | ELISA、流式细胞术、中和、功能测定,如生物分析PK和ADA测定,以及用于研究受小鼠CD11c蛋白影响的生物途径的测定。 |
文献
PA007390.m1: Syd Labs体内实验级重组抗小鼠CD11c单克隆抗体(克隆号N418),小鼠IgG1 Kappa(In vivo Grade Recombinant Anti-mouse CD11c Monoclonal Antibody, Mouse IgG1 Kappa (Clone: N418))
抗小鼠CD11c单克隆抗体(克隆号 N418,小鼠 IgG1 kappa)可与小鼠 CD11c 蛋白发生反应。CD11c 是树突状细胞(DC)最广泛使用的标志物。CD11c 蛋白参与细胞黏附,并在吞噬作用、细胞迁移以及 T 细胞激活等多个生理过程中发挥重要作用。CD11c 通过与 ICAM-1、纤维蛋白原(fibrinogen)和 iC3b 等分子结合协助细胞黏附;帮助细胞吞噬与消化其他细胞;协助朗格汉斯细胞(Langerhans cells)激活 T 细胞;调节中性粒细胞的成熟与功能;并帮助树突状细胞捕获和激活其他细胞。除了树突状细胞和组织巨噬细胞外,CD11c 还在不同的 B 细胞淋巴瘤中表达(包括慢性淋巴细胞白血病)。此外,在小鼠神经系统中也发现了表达 CD11c 的细胞。
我们的重组 N418 抗体(重组抗小鼠 CD11c 单抗)包含该抗小鼠 CD11c 单克隆抗体(杂交瘤克隆名称或编号:N418)的部分(可变区)或完整氨基酸序列。
抗小鼠CD11c单抗(N418)部分引用文献:
1. Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice
Lai, R., et al. Cell Death Dis. 2021 Aug 10;12(8):780. PMID: 34376646
“Age-associated B cells (ABCs), characterized by the expression of CD11c and T-bet, accumulate in autoimmune diseases. This study demonstrates that the altered function and differentiation of ABCs contribute significantly to the female bias in lupus-prone mice. Understanding the role of CD11c+ B cells provides critical insights into the pathogenesis and therapeutic targeting of systemic lupus erythematosus.”
2. Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs
Böttcher, C., et al. Immunity. 2020 Nov 17;53(5):1038-1053.e9. PMID: 33113344
“Dendritic cells and microglia play distinct, non-redundant roles in regulating neuroinflammation. This study characterizes brain-resident CD11c+ classical dendritic cells (cDCs) and microglia during inflammatory states. The findings reveal that type 1 cDCs exert protective immune effects in the inflamed central nervous system, highlighting their potential as therapeutic targets.”
3. Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis
Li, X., et al. Front Immunol. 2022 Feb 10;13:836488. PMID: 35222441
“Mature dendritic cells (DCs) are central regulators of autoimmune responses in rheumatoid arthritis. This study demonstrates that therapeutic administration of an anti-mouse CD83 monoclonal antibody selectively targets mature CD11c+ DCs to provide protection against collagen-induced arthritis. These results suggest that targeting DC activation pathways represents a highly effective immunotherapeutic strategy for treating autoimmune joint inflammation.”
4. Dynamics of host immune response development during Schistosoma mansoni infection
van den Biggelaar, F. M. S. J., et al. PLoS Negl Trop Dis. 2022 Aug 9;16(8):e0010651. PMID: 35943960
“Host immune responses undergo complex temporal dynamics during progressive parasitic infections. This study tracks the initiation and development of immune reactions during Schistosoma mansoni infection in mouse models. The analysis highlights the pivotal role of CD11c+ myeloid populations in driving antigen presentation and shaping the downstream adaptive immune landscape.”
5. CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity
Knier, J. P. S., et al. J Exp Med. 2021 May 3;218(5):e20201111. PMID: 33818556
“Persistent neuroinflammation in autoimmune diseases requires continuous reactivation of encephalitogenic T cells. This study identifies a unique subset of CD11c+ CD88+ CD317+ myeloid cells as key drivers of chronic central nervous system autoimmunity. This distinct cell population accumulates in inflamed tissues and exhibits superior antigen-presenting capabilities that sustain local T-cell responses.”

